低频经颅磁刺激联合认知行为疗法对帕金森病合并睡眠障碍患者的疗效观察

柳敏芬; 蓝丽康; 吕锦; 梁燕飞; 徐如月; 吴泓蔚

doi:10.16766/j.cnki.issn.1674-4152.004205

低频经颅磁刺激联合认知行为疗法对帕金森病合并睡眠障碍患者的疗效观察

doi: 10.16766/j.cnki.issn.1674-4152.004205

温州医科大学附属第六医院丽水市人民医院神经内科，浙江丽水 323000

基金项目:

浙江省医药卫生科技计划项目 2022KY1443

详细信息

通讯作者:
吴泓蔚，E-mail：whwenjoy@163.com

中图分类号: R742.5 R493
计量
- 文章访问数: 1
- HTML全文浏览量: 2
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2025-03-12

Efficacy of low frequency transcranial magnetic stimulation combined with cognitive behavioral therapy in patients with Parkinson's disease complicated with sleep disorders

Department of Neurology, Lishui People ' s Hospital, Wenzhou Medical College Affiliated Sixth Hospital, Lishui, Zhejiang 323000, China

摘要

摘要: 目的探讨低频经颅磁刺激(LF-TMS)联合认知行为疗法(CBT)治疗帕金森病(PD)合并睡眠障碍患者的临床效果，为改善PD患者睡眠质量提供指导方案。方法选取2021年10月—2023年10月丽水市人民医院收治的PD合并睡眠障碍患者92例，采用随机数表法分为观察组和对照组，各46例，2组均给予LF-TMS治疗，观察组在LF-TMS治疗基础上行CBT干预。采用匹兹堡睡眠质量指数(PSQI)量表、帕金森睡眠量表(PDSS)、心肺耦合(CPC)-测评系统评估干预前、4周时的睡眠状况，并比较2组干预后3个月的临床疗效。结果 2组干预后4周时的PSQI、ESS量表评分均明显低于同组干预前(P＜0.001)，PDSS评分均明显高于干预前(P＜0.001)；观察组干预后4周时的PSQI量表评分指标均明显低于同期对照组(P＜0.05)；观察组临床总有效率明显高于对照组[44例(95.65%) vs. 36例(78.26%)，χ²=6.133, P=0.013]；干预前，2组CPC指标比较差异无统计学意义(P＞0.05)；干预后，观察组上述指标均明显优于对照组(P＜0.01)。结论 LF-TMS联合CBT应用于PD合并睡眠障碍患者治疗效果显著，能明显改善PD患者睡眠障碍，提高睡眠质量。
- 帕金森病 /
- 低频经颅磁刺激 /
- 认知行为疗法 /
- 睡眠障碍
Abstract: Objective To explore the clinical effect of low-frequency transcranial magnetic stimulation (LF-TMS) combined with cognitive behavioral therapy (CBT) in the treatment of patients with Parkinson ' s disease (PD) complicated with insomnia disorder, and to provide guidance for improving the sleep quality of PD patients. Methods A total of 92 patients with PD complicated with sleep disorders admitted to Lishui People ' s hospital from October 2021 to October 2023 were selected and randomly divided into an observation group and a control group, with 46 cases in each group, by the random number table method. Both groups were treated with LF-TMS, and the observation group received CBT intervention on the basis of LF-TMS treatment. The Pittsburgh sleep quality index (PSQI) scale, Parkinson ' s disease sleep scale (PDSS), and cardiopulmonary coupling (CPC)- assessment system were used to evaluate the sleep status before the intervention and at 4 weeks, and the clinical efficacy of the two groups 3 months after the intervention was compared. Results The PSQI scale score indicators of the two groups at 4 weeks after the intervention were significantly lower than the corresponding indicators of the same group before the intervention (P < 0.01), and the PDSS scores were significantly higher than the indicators before the intervention (P < 0.01). The PSQI scale score indicators of the observation group at 4 weeks after the intervention were significantly lower than those of the control group at the same period (P < 0.05). The total clinical effective rate of the observation group was significantly higher than that of the control group [44 cases (95.65%) vs. 36 cases (78.26%), χ²=6.133, P=0.013]. Before the intervention, there was no statistically significant difference in the CPC index between the two groups (P>0.05). After the intervention, the above indicators in the observation group were significantly better than those in the control group (P < 0.01). Conclusion The utilization of LF-TMS in conjunction with CBT in the treatment of PD patients with sleep disorders has significant clinical effect, which can significantly improve the sleep disorders of PD patients and improve the sleep quality.
- Parkinson ' s disease /
- Low frequency transcranial magnetic stimulation /
- Cognitive behavioral therapy /
- Sleep disorder
利益冲突 无

HTML全文

表 1 2组PD合并睡眠障碍患者临床资料比较

Table 1. Comparison of clinical data in PD patients with sleep disorder between two groups

组别	例数	性别[例(%)]		年龄(x ±s，岁)	PD病程(x ±s，岁)	失眠病程(x ±s，岁)	霍亚分期[例(%)]
组别	例数	男性	女性	年龄(x ±s，岁)	PD病程(x ±s，岁)	失眠病程(x ±s，岁)	1期	2~3期
观察组	46	25(54.35)	21(45.65)	68.59±2.85	6.76±1.52	4.27±1.84	17(36.96)	29(63.04)
对照组	46	22(47.83)	24(52.17)	69.25±2.93	6.29±1.28	4.21±1.93	20(43.48)	26(56.52)
统计量		0.391^a		1.095^b	1.604^b	0.153^b	0.407^a
P值		0.532		0.276	0.112	0.879	0.524
注：^a为χ²值，^b为t值。

下载: 导出CSV

表 2 CPC监测睡眠质量总评参考值

Table 2. CPC reference for overall sleep quality

指标	参考值
睡眠总时间(TST)	8 h
睡眠效率(TST/TIB)	≥90%
熟睡时间	3.3~5.2 h
浅睡时间	≤2.9 h
REM睡眠时间	≤1 h
觉醒时间	≤1 h
睡眠呼吸睡眠指数(AHI)	< 5次/h

下载: 导出CSV

表 3 2组PD合并睡眠障碍患者PSQI评分比较(x ±s，分)

Table 3. Comparison of PSQI scores in PD patients with sleep disorders between two groups(x ±s, points)

组别	例数	干预前	干预后4周
观察组	46	13.53±1.49	6.18±1.76^b
对照组	46	13.65±1.51	9.58±1.78^b
统计量		0.647^a	9.859^c
P值		0.695	＜0.001
注：^a为t值，^c为F值；与同组干预前比较，^bP＜0.01。

下载: 导出CSV

表 4 2组PD合并睡眠障碍患者PDSS评分比较(x ±s，分)

Table 4. Comparison of PDSS scores of PD patients with sleep disorders between two groups(x ±s, points)

组别	例数	干预前	干预后4周
观察组	46	79.68±7.79	108.68±9.82^b
对照组	46	78.97±8.68	98.58±9.86^b
统计量		0.229^a	4.923^c
P值		0.819	＜0.001
注：^a为t值，^c为F值；与同组干预前比较，^bP＜0.01。

下载: 导出CSV

表 5 2组PD合并睡眠障碍患者CPC睡眠监测指标比较(x ±s)

Table 5. Comparison of changes of CPC sleep monitoring indexes in PD patients with sleep disorders between two groups(x ±s)

组别	例数	睡眠总时间(h)			睡眠效率(%)		浅睡时间(h)			REM睡眠时间(min)
组别	例数	干预前	干预后4周		干预前	干预后4周	干预前	干预后4周		干预前	干预后4周
观察组	46	5.25±0.57	7.63±0.65^b		63.85±2.78	85.66±3.82^b	3.92±0.78	2.31±0.68^b		81.58±2.78	55.82±2.69^b
对照组	46	5.22±0.68	6.28±0.75^b		63.62±2.69	71.95±3.86^b	3.82±0.55	2.91±0.42^b		81.82±2.55	72.63±2.72^b
统计量		0.413^a	9.226^c		0.403^a	17.122^c	0.447^a	9.008^c		-0.431	-40.942
P值		0.681	＜0.001		0.688	＜0.001	0.657	＜0.001		0.667	< 0.001

组别	例数	熟睡时间(h)				觉醒时间(h)			睡眠呼吸睡眠指数(次/h)
组别	例数	干预前		干预后4周		干预前	干预后4周		干预前		干预后4周
观察组	46	2.23±0.57		3.69±0.25^b		2.52±0.23	1.56±0.26^b		7.63±0.82		83.89±0.68^b
对照组	46	2.27±0.21		3.28±0.17^b		2.61±0.31	1.98±0.18^b		44.87±5.75		72.83±6.92^b
统计量		0.711^a		7.415^c		1.338^a	5.092^c		-1.378^a		6.986^c
P值		0.479		＜0.001		0.184	＜0.001		0.172		< 0.001
注：^a为t值，^c为F值；与同组干预前比较，^bP＜0.01。

下载: 导出CSV

表 6 2组PD合并睡眠障碍患者临床总有效率比较[例(%)]

Table 6. Comparison of the total clinical effective rate between the two groups of patients with PD and sleep disorders[cases (%)]

组别	例数	显效	有效	无效	总有效
观察组	46	21(45.65)	23(50.00)	2(4.35)	44(95.65)
对照组	46	14(30.43)	22(47.83)	10(21.74)	36(78.26)
注：2组总有效率比较，χ²=6.133，P=0.013。

下载: 导出CSV

参考文献(24)

[1]	丁妹, 朱雨婷, 陆珍辉, 等. 影响帕金森病患者认知功能的独立危险因素分析[J]. 中国实用神经疾病杂志, 2020, 23(18): 1590-1595. DING M, ZHU Y T, LU Z H, et al. Analysis of independent risk factors affecting cognitive function in patients with Parkinson's disease[J]. Chinese Journal of Practical Nervous Diseases, 2020, 23(18): 1590-1595.
[2]	刘春风, 沈赟. 重视帕金森病睡眠障碍的规范管理[J]. 中华神经科杂志, 2019, 52(5): 361-363. LIU C F, SHEN Z. Attention should be paid to the standardized management of sleep disorders in Parkinson's disease[J]. Chinese Journal of Neurology, 2019, 52(5): 361-363.
[3]	中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍学组. 中国帕金森病睡眠障碍管理专家共识[J]. 中华神经科杂志, 2022, 55(5): 441-451. Parkinson's Disease and movement Disorders Group, Chinese Medical Association Neurology Branch, and Parkinson's Disease and movement Disorders Group, Chinese Medical Doctor Association Neurology Branch. Expert consensus on sleep disorder management of Parkinson's disease in China[J]. Chinese Journal of Neurology, 2022, 55(5): 441-451.
[4]	魏全福. 小剂量氯氮平治疗帕金森病合并睡眠障碍的疗效观察[J]. 世界睡眠医学杂志, 2020, 7(7): 1136-1137. WEI Q F. Efficacy of low dose clozapine in the treatment of Parkinson's disease complicated with sleep disorders[J]. World Journal of Sleep Medicine, 2020, 7(7): 1136-1137.
[5]	RUTTEN S, VRIEND C, BERENDSE H W, et al. Anxiety, depression and sleep disorders in Parkinson's disease: a complex interaction between body and mind[J]. Tijdschr Psychiatr, 2020, 62(1): 62-72.
[6]	王霞, 舒啟娥, 张怀倩. 认知行为疗法对失眠症患者睡眠质量和心理健康水平的影响研究[J]. 心理月刊, 2022, 22(17): 85-87. WANG X, SHU Q E, ZHANG H Q. Effect of cognitive behavioral therapy on sleep quality and mental health of insomniacs[J]. Psychologies Magazine, 2022, 22(17): 85-87.
[7]	中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49(4): 268-271. Parkinson's Disease and movement Disorders Group, Chinese Medical Association Neurology Branch, and Parkinson's Disease and movement Disorders Department, Chinese Medical Doctor Association Neurology Branch. Diagnostic criteria for Parkinson's Disease in China (2016 edition)[J]. Chinese Journal of Neurology, 2016, 49(4): 268-271.
[8]	高和. 《国际睡眠障碍分类》(第三版)慢性失眠障碍的诊断标准[J]. 世界睡眠医学杂志, 2018, 5(5): 555-557. GAO H. International Classification of Sleep Disorders (3rd Edition) Diagnostic criteria for chronic insomnia disorders[J]. World Journal of Sleep Medicine, 2018, 5(5): 555-557.
[9]	马桂月, 沈志莹, 乔莉, 等. 认知行为疗法对高血压焦虑抑郁患者干预效果研究进展[J]. 中华高血压杂志, 2021, 29(4): 328-332. MA G Y, SHEN Z Y, QIAO L, et al. Research progress on the effect of cognitive behavioral therapy on patients with hypertension, anxiety and depression[J]. Chinese Journal of Hypertension, 2021, 29(4): 328-332.
[10]	张雅西, 林彩单, 黄向东. 乌灵胶囊联合认知行为疗法治疗帕金森病睡眠障碍临床研究[J]. 新中医, 2023, 55(19): 43-47. ZHANG Y X, LIN C D, HUANG X D. Clinical study on sleep disorder of Parkinson's disease treated by Wuling capsule combined with cognitive behavioral therapy[J]. Journal of New Chinese Medicine, 2023, 55(19): 43-47.
[11]	桂小红, 王黎萍, 吴承龙, 等. 早期与中晚期帕金森病患者睡眠障碍比较及其对生活质量的影响[J]. 中华神经医学杂志, 2019, 18(1): 22-27. GUI X H, WANG L P, WU C L, et al. A comparison of sleep disorders and their impact on quality of life in patients with early and advanced Parkinson's disease[J]. Chinese Journal of Neurology, 2019, 18(1): 22-27.
[12]	张慧芳, 郭华, 贾金鼎, 等. 认知行为疗法联合低频经颅磁刺激治疗失眠症的效果探讨[J]. 临床医学工程, 2022, 29(4): 451-452. ZHANG H F, GUO H, JIA J D, et al. Effect of cognitive behavioral therapy combined with low frequency transcranial magnetic stimulation in the treatment of insomnia[J]. Clinical Medical & Engineering, 2022, 29(4): 451-452.
[13]	陆晓双, 李成, 高霞, 等. 帕金森病伴睡眠障碍的研究进展[J]. 中国实用神经疾病杂志, 2024, 27(1): 108-112. LU X S, LI C, GAO X, et al. Research progress of Parkinson's disease with sleep disorders[J]. Chinese Journal of Practical Nervous Diseases, 2024, 27(1): 108-112.
[14]	李青, 赵盼盼, 徐志秀, 等. 氯氮平联合多巴丝肼治疗帕金森病并睡眠障碍的临床效果[J]. 新乡医学院学报, 2020, 37(12): 1138-1142. LI Q, ZHAO P P, XUE Z X, et al. Clinical effect of clozapine combined with dopa serazid in the treatment of Parkinson's disease and sleep disorders[J]. Journal of Xinxiang Medical College, 2020, 37(12): 1138-1142.
[15]	田祥奇, 王皓, 徐新荣, 等. 超低频经颅磁刺激对帕金森病睡眠障碍患者的疗效观察[J]. 山东大学学报(医学版), 2022, 12(60): 20-25. TIAN X Q, WANG H, XU X R, et al. Effect of ultra-low frequency transcranial magnetic stimulation on patients with sleep disorder of Parkinson's disease[J]. Journal of Shandong University (Health Sciences), 2022, 12(60): 20-25.
[16]	俞晓岚, 陈欢林. 重复经颅磁刺激治疗帕金森病失眠患者的临床效果及预后分析[J]. 中外医疗, 2022, 41(4): 20-24. YU X L, CHEN H L. Clinical effect and prognosis analysis of repetitive transcranial magnetic stimulation for insomnia patients with Parkinson's disease[J]. China Foreign Medical Treatment, 2022, 41(4): 20-24.
[17]	毛晶, 洪永锋, 冯小军, 等. 不同频率重复经颅磁刺激对脑卒中患者认知和运动的影响[J]. 中华全科医学, 2022, 20(6): 1036-1040. doi: 10.16766/j.cnki.issn.1674-4152.002518 MAO J, HONG Y F, FENG X J, et al. The influence of repetitive transcranial magnetic stimulation at different frequencies on the cognition and movement of stroke patients[J]. Chinese Journal of General Practice, 2022, 20(6): 1036-1040. doi: 10.16766/j.cnki.issn.1674-4152.002518
[18]	李晓芳, 张鹏辽, 惠玲利, 等. 团体认知行为疗法对失眠患者的疗效分析[J]. 心理月刊, 2023, 18(1): 148-150. LI X F, ZHANG P L, HUI L L, et al. Analysis of therapeutic effect of group cognitive behavioral therapy on insomnia patients[J]. Psychologies Magazine, 2023, 18(1): 148-150.
[19]	罗明民, 张红雷. 低频经颅磁刺激联合认知行为疗法对帕金森病的影响[J]. 中国老年学杂志, 2019, 11(39): 5556-5559. LUO M M, ZHANG H L. Effects of low frequency transcranial magnetic stimulation combined with cognitive behavioral therapy on Parkinson's disease[J]. Chinese Journal of Gerontology, 2019, 11(39): 5556-5559.
[20]	陈毓茜, 李满连. 低频重复经颅磁刺激联合多巴丝肼治疗帕金森病自主神经功能障碍患者的效果[J]. 中国民康医学, 2021, 33(13): 31-33. CHEN Y X, LI M L. Efficacy of low-frequency repetitive transcranial magnetic stimulation combined with dopa serazine in the treatment of autonomic dysfunction in Parkinson's disease[J]. Medical Journal of Chinese People's Health, 2021, 33(13): 31-33.
[21]	邵祥芸, 赵敏, 安瑞丽, 等. 认知行为疗法治疗慢性失眠临床疗效的系统评价和Meta分析[J]. 临床荟萃, 2019, 34(5): 447-454. SHAO X Y, ZHAN M, AN R L, et al. A systematic review and meta-analysis of the clinical efficacy of behavioral therapy for chronic insomnia[J]. Clinical Focus, 2019, 34(5): 447-454.
[22]	黄淑娟. 失眠认知行为对原发性高血压合并睡眠障碍患者睡眠质量的影响[J]. 世界睡眠医学杂志, 2023, 10(4): 936-938. HUANG S J. Effects of cognitive behavior on sleep quality in patients with essential hypertension complicated with sleep disorders[J]. World Journal of Sleep Medicine, 2023, 10(4): 936-938.
[23]	杨梦姝, 孔晓云, 李欢, 等. 失眠的认知行为疗法对帕金森病伴失眠患者影响的临床研究[J]. 昆明医科大学学报, 2023, 44(8): 117-122. YANG M S, KONG X Y, LI H, et al. A clinical study on the effect of cognitive behavioral therapy for insomnia on patients with Parkinson's disease and insomnia[J]. Journal of Kunming Medical University, 2023, 44(8): 117-122.
[24]	ICEL S, BASOGU C. Effects of progressive muscle relaxation training with music therapy on sleep and anger of patients at community mental health center[J]. Complement Ther Clin Pract, 2021, 43: 101338. DOI: 10.1016/j.ctcp.2021.101338.